Protected: Case Reports – [ immunotherapy ]
There is no excerpt because this is a protected post.
Very important fact about GcMAF treatment.
There are different generations in GcMAF therapy. The first generation GcMAF was developed over 20 years ago. Due to limited testing and clinical use, the efficacy is unknown.
2019 Integrative Medical Therapies conference – Osaka, Japan
Thank you very much for your participation at the Saisei Mirai 2019 Integrative Medical Therapies conference in Osaka. Contents If you would like to learn more about advanced integrative medical therapies including treatments available in our clinics and treatment cases, please participate in this conference and take advantage of this great educational opportunity. – Dr Toshio Inui, CEO – This medical conference is a conference gathering of cancer therapy experts from both Japan and abroad. We will give lectures on mechanisms and cases of each treatment by domestic and international specialists including Dr Toshio Inui, CEO and Dr Shinichiro Akiyama, General Director, Saisei Mirai. All lectures will be have simulations […]
GcMAF (Gc Protein derived Macrophage Activating Factor)
New GcMAF NEW GcMAF is produced using a patented process developed in Japan by Saisei Mirai, in collaboration with researchers from the University of Tokushima, who have been conducting GcMAF research for over 20 years. Manufactured in our sterile cell processing facility, this advanced formulation is 10–15 times more concentrated than conventional GcMAF and offers significantly enhanced stability and bioactivity. Clinically, this higher-concentration GcMAF has demonstrated a favorable safety profile, with the vast majority of patients experiencing no adverse effects. In rare cases (approximately 1 in 100), mild and transient symptoms such as low-grade fever or eczema may occur. Its improved resistance to oxidation contributes to greater stability, making NEW […]
Research and references GcMAF
GcMAF (Gc Protein derived Macrophage Activating Factor) Research and references GcMAF
GcMAF Therapy for Autism
Autism spectrum disorder (ASD) varies in its impact on communication, behavior, and social interaction, requiring tailored support levels. Our clinic offers innovative immunotherapy using GcMAF product, developed in collaboration with Japanese research institutions, to safely enhance ASD symptom management at the cellular level with minimal effort required from patients. The immune system and autism Recently it is becoming clear that immune system dysfunction plays an important role in autism Altered immunity in individuals with autism Researchers have observed differences in the immune system of individuals with autism, including changes in things like cytokines, immunoglobulins, inflammation and how cells are activated. They have also noticed alterations in various immune cells, such […]
Dietary MAF (New generation)
MAF Series are a food which helps boost the immune system.